These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 1980108

  • 1. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C, Schröppel K, Lohoff M, Röllinghoff M, Solbach W.
    Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
    [Abstract] [Full Text] [Related]

  • 2. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P, Pearce E, Natovitz P, Sher A.
    J Immunol; 1987 Jul 01; 139(1):221-7. PubMed ID: 3495599
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity.
    Titus RG, Müller I, Kimsey P, Cerny A, Behin R, Zinkernagel RM, Louis JA.
    Eur J Immunol; 1991 Mar 01; 21(3):559-67. PubMed ID: 1672641
    [Abstract] [Full Text] [Related]

  • 8. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM.
    J Immunol; 1987 Aug 15; 139(4):1303-9. PubMed ID: 3112230
    [Abstract] [Full Text] [Related]

  • 9. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Kammerer E, Bogdan C, Röllinghoff M.
    J Immunol; 1986 Jul 15; 137(2):702-7. PubMed ID: 3487578
    [Abstract] [Full Text] [Related]

  • 10. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA, Ogunremi O, Menon JN.
    Behring Inst Mitt; 1997 Feb 15; (98):153-9. PubMed ID: 9382736
    [Abstract] [Full Text] [Related]

  • 11. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
    Moll H, Mitchell GF.
    J Parasitol; 1988 Dec 15; 74(6):993-8. PubMed ID: 3264023
    [Abstract] [Full Text] [Related]

  • 12. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG, Lima GC, Engers HD, Louis JA.
    J Immunol; 1984 Sep 15; 133(3):1594-600. PubMed ID: 6205088
    [Abstract] [Full Text] [Related]

  • 13. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
    Webb JR, Kaufmann D, Campos-Neto A, Reed SG.
    J Immunol; 1996 Dec 01; 157(11):5034-41. PubMed ID: 8943412
    [Abstract] [Full Text] [Related]

  • 14. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY, Dhaliwal JS.
    J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY, Singleton A, Cillari E, Howard JG.
    J Immunol; 1985 Sep 15; 135(3):2102-7. PubMed ID: 3160786
    [Abstract] [Full Text] [Related]

  • 16. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages.
    Shimizu Y, Takagi H, Nakayama T, Yamakami K, Tadakuma T, Yokoyama N, Kojima N.
    Parasite Immunol; 2007 May 15; 29(5):229-39. PubMed ID: 17430546
    [Abstract] [Full Text] [Related]

  • 17. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC, Curotto de Lafaille MA, Collet de Araujo Lima GM, de Almeida Abrahamsohn I.
    Cell Immunol; 1996 May 25; 170(1):41-53. PubMed ID: 8660798
    [Abstract] [Full Text] [Related]

  • 18. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G.
    Eur J Immunol; 1996 Jul 25; 26(7):1553-9. PubMed ID: 8766560
    [Abstract] [Full Text] [Related]

  • 19. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract.
    Scott P, Pearce E, Natovitz P, Sher A.
    J Immunol; 1987 Nov 01; 139(9):3118-25. PubMed ID: 3499465
    [Abstract] [Full Text] [Related]

  • 20. TNF-alpha reverses the disease-exacerbating effect of subcutaneous immunization against murine cutaneous leishmaniasis.
    Liew FY, Li Y, Yang DM, Severn A, Cox FE.
    Immunology; 1991 Oct 01; 74(2):304-9. PubMed ID: 1748478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.